In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Weider mass market supplement sales up 19.5% to $54.4 mil. through nine months -- IPO.

This article was originally published in The Tan Sheet

Executive Summary

WEIDER MASS MARKET SUPPLEMENT SALES UP 19.5% TO $54.4 MIL. through the nine-month period ended Feb. 28, Weider Nutrition International reports in an April 30 stock prospectus for its recently completed initial public offering. Over one-third of company sales (35.9%) were to mass volume retailers through the first nine months of FY 1997. The supplements firm attributes the rise to increased market penetration and new product introductions.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts